Compared to hGH, AOD9604 offered similar adipose tissue effects without significantly increasing systemic growth factors, such as IGF-1
Research has confirmed that the peptide lacks the systemic effects of growth hormone, showing no impact on IGF-1 levels, glucose metabolism, or growth-promoting effects in other tissues
I also got headaches and pain around the eye and I am Newley loaded up and they have settled down quite quickly
This is the single best proxy for visceral fat changes and responds particularly well to the AOD 9604 mechanism
On any insulin syringe, 100 units equals 1 mL, so 50 units is 0.5 mL and 10 units is 0.1 mL
The mechanism through which it promotes fat loss, primarily beta-3 adrenergic receptor activation, is completely separate from IGF-1 signaling